Guenther Hochhaus

Guenther Hochhaus, Ph.D.

Professor

Department: Pharmaceutics
Business Phone: (352) 273-7861
Business Email: hochhaus@cop.ufl.edu

About Guenther Hochhaus

Hochhaus evaluates anti-asthma drugs in the body (pharmacokinetics) to understand the relationship between the drug properties and the pharmacodynamic effects. His work linking pharmacokinetic-pharmacodynamic approaches with a rational drug delivery design has proven to be a powerful tool in streamlining drug development for inhalation drugs. To provide a strong research program in pharmaceutics and actively seek outside support; to participate in teaching and education of undergraduate, graduate students and postdoctoral associates. The courses include undergraduate class “Principles of Dose Optimization I (PHA 5127)”, and graduate class “Pharmaceutical Analysis I (PHA 6416)”.

Publications

2019 European Journal of Pharmaceutical Sciences
2013 Journal of Aerosol Medicine and Pulmonary Drug Delivery

Grants

Oct 2019 ACTIVE
GSK Fellowship – Jose Francis Year 1
GLAXO SMITHKLINE · Principal Investigator
Sep 2019 ACTIVE
Systematic evaluation of the ex-throat plume properties of MDI formulations
US FOOD AND DRUG ADMN · Principal Investigator
Sep 2019 ACTIVE
A Multiscale Computational Framework for Bioequivalence of Orally Inhaled Drugs
CFD RESEARCH CORP · Principal Investigator
Jul 2019 ACTIVE
Clinical Pharmacokinetics/Dynamics Fellowship 2018-2019 – Sagar Bachav
GLAXO SMITHKLINE · Principal Investigator
Jul 2018 – Jul 2019
Clinical Pharmacokinetics/Dynamics Fellowship 2017-2018 – Sagar Bachav
GLAXO SMITHKLINE · Principal Investigator
Sep 2016 – Mar 2018
Pharmacokinetic Comparison of Locally Acting Orally Inhaled Drug Products
US FOOD AND DRUG ADMN ·
Feb 2016 – Dec 2016
Methacholine stability test over 8 months (months 0-8)-batch 2
COMPLEWARE CORPORATION · Principal Investigator
Aug 2015 – Nov 2016
Methacholine Stability Testing with Ion
COMPLEWARE CORPORATION · Principal Investigator
Jul 2015 – Jan 2017
Further Characterization of the Modified Chi-square Rati
INTL PHARM AEROSOL CONSRT REG AND SCIENC · Principal Investigator
Apr 2015 ACTIVE
Peptidic Kappa Opiod Receptor Ligands as Potential Treat
NATL INST OF HLTH NIDA · Project Manager
Mar 2015 – Dec 2018
Determination of Drug Levels in Interstitial Fluid for Therapeutic IgG by Microdialysis and its Relevance for Pharmacokinetic and Pharmacodynamic
HOFFMANN LA ROCHE · Principal Investigator
Dec 2014 – Feb 2020
Comprehensive Evaluation of Formulation Effects on Metered Dose Inhaler Performance
US FOOD AND DRUG ADMN · Principal Investigator
Sep 2013 – Apr 2020
Study to Investigate the Sensitivity of Pharmacokinetics in Detecting Differences in Physicochemical Properties of the Active in Suspension Nasal Products for Local Action
US FOOD AND DRUG ADMN ·
Sep 2013 – Dec 2016
Stability of Fluticasone Proprionate Capsules for Inhala
FEFA · Principal Investigator
Sep 2013 – Feb 2017
An Optimized Dissolution Test System for Orally Inhaled Drugs: Development and Va
US FOOD AND DRUG ADMN · Principal Investigator
Aug 2012 – Jul 2017
Does P-glycoprotein Restrict Access of Budesonide but not Fluticasone Propionate to the Placenta and Fetus?
ASTRAZENECA · Principal Investigator
Sep 2011 – Sep 2016
Pharmacokinetic Comparison of Locally Acting Inhaled
FEFA · Principal Investigator

Patents

Issued November 2001
Development of a Bootstrap Application for Resampling Pharmacokinetic and Toxicokinetic Data.
#Tu1021748
Issued January 2006
Methods for Preparing Coated Drug Particles and Pharmaceutical Formulations Thereof
#6,984,404

Education

Ph.D.
1984 · University of Munster
B.Sc.
1980 · Elisabeth Apotheke

Contact Details

Phones:
Business:
(352) 273-7861
Emails: